Kramer Levin adds two life sciences partners in New York

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Kramer Levin adds two life sciences partners in New York

Brian Slater and Gregory Sephton have joined Kramer Levin Naftalis & Frankel in New York. They were previously at Fitzpatrick Cella Harper & Scinto

kramer-levin-adds-two.jpg

They both have more than 20 years of experience handling patent litigation involving a broad range of technologies in the life sciences.

Slater (top right) has served as lead counsel to companies such as Gilead, Merck, and Sanofi.

Sephton (bottom right) has been involved in litigating and trying patent cases for a number of technology leaders, including Emory University, Astra Zeneca, Novartis and Warner Chilcott.

The move follows Kramer Levin’s recent hiring of Christine Willgoos, a life sciences patent litigator who came from Paul Hastings.

more from across site and SHARED ros bottom lb

More from across our site

Andrew Blattman, who helped IPH gain significant ground in Asia and Canada, will leave in the second half of 2026
The court ordering a complainant to rank its arguments in order of potential success and a win for Edwards Lifesciences were among the top developments in recent weeks
Frederick Lee has rejoined Boies Schiller Flexner, bolstering the firm’s capabilities across AI, media, and entertainment
Nirav Desai and Sasha S Rao at Sterne, Kessler, Goldstein & Fox explore how companies’ efforts to manage tariffs by altering corporate structures can undermine their ability to assert their patents and recover damages
Monika Żuraw, founder of Żuraw & Partners, discusses why IP should be part of the foundation of a business, and taking on projects that others walk away from
Lawyers say attention will turn to the UK government’s AI consultation after judgment fails to match pre-trial hype
Susan Keston and Rachel Fetches at HGF explain why the CoA’s decision to grant the UPC’s first permanent injunction demonstrates the court’s readiness to diverge from national court judgments
IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ with ‘Band-Aid’ and ‘Tylenol’
Stability AI, represented by Bird & Bird, is not liable for secondary copyright infringement, though Fieldfisher client Getty succeeds in some trademark claims
Plasseraud IP says it is eyeing AI and quantum computing expertise with new hire from Cabinet Netter
Gift this article